Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05912556 · ClinicalTrials.gov registry record · NA

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

A NA study of Cognition and Brain Function, sponsored by Lumos Labs.

Active
Registry status
NA
Development phase
816
Enrollment target
1
Study location

NCT05912556 is a NA study of Cognition and Brain Function that is active but no longer recruiting, run by Lumos Labs. The registered enrollment target is 816 participants, above the 148-participant average among 35 other Cognition trials with a reported enrollment target (451% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05912556, a NA study of Cognition and Brain Function, is active but no longer recruiting, sponsored by Lumos Labs.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
816 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

Interventions

  • DEVICE Digital Program 1
  • DEVICE Digital Program 2

Study Locations (1)

California

  • Lumos Labs, Inc. - San Francisco

Trial Details

FieldValue
Enrollment Target 816 participants
Start Date 2023-07-05
Est. Completion 2025-05-15
Phase NA

Sponsor

Lumos Labs

9 total trials

What the Registry Record Tells You About NCT05912556

The ClinicalTrials.gov registry entry for NCT05912556 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 816 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 148-participant average among 35 other Cognition trials with a reported enrollment target (451% higher). The listed sponsor is Lumos Labs, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cognition appearing as the primary indexed condition, and to 2 interventions - of which Digital Program 1 is the first listed.

NCT05912556 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05912556 about?

NCT05912556 is a clinical study titled "Brain Response to an Intervention Using Guided, At-Home Technology for the Mind". The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

What is the current status of trial NCT05912556?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 816 participants. The study started on 2023-07-05. Estimated completion is 2025-05-15.

What conditions does trial NCT05912556 study?

This clinical trial studies the following conditions: Cognition, Brain Function, Brain Structure, Brain Health.

What interventions are being tested in trial NCT05912556?

The interventions under investigation include: Digital Program 1 (DEVICE), Digital Program 2 (DEVICE).

Who is sponsoring clinical trial NCT05912556?

This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05912556 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.